101 related articles for article (PubMed ID: 10560382)
1. [Dihydropyrimidine dehydrogenase gene expression in patients with hepatic metastases from colorectal cancer].
Shirota Y; Ichikawa W; Yamada H; Uetake H; Nihei Z; Sugihara K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1729-31. PubMed ID: 10560382
[TBL] [Abstract][Full Text] [Related]
2. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].
Ishibashi K; Sobajima J; Ishiguro T; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2232-5. PubMed ID: 20037380
[TBL] [Abstract][Full Text] [Related]
3. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
4. Regulation of dihydropyrimidine dehydrogenase in colorectal cancer.
Johnston SJ; Ridge SA; Cassidy J; McLeod HL
Clin Cancer Res; 1999 Sep; 5(9):2566-70. PubMed ID: 10499634
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.
Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K
Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742
[TBL] [Abstract][Full Text] [Related]
6. [Thymidylate synthase and dihydropyrimidine dehydrogenase activity in a metastatic liver tumor from colorectal cancer].
Umekita N; Tanaka S; Abe H; Kitamura M
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1883-5. PubMed ID: 11086436
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of determinations of dihydropyrimidine dehydrogenase levels in primary and hepatic lesions of colorectal cancer patients].
Ishida H; Hashimoto D; Inokuma S; Takeuchi I; Nakada H; Ohsawa T; Hoshino T; Murata N; Fujioka M; Idezuki Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1879-82. PubMed ID: 11086435
[TBL] [Abstract][Full Text] [Related]
8. Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer.
Uetake H; Ichikawa W; Takechi T; Fukushima M; Nihei Z; Sugihara K
Clin Cancer Res; 1999 Oct; 5(10):2836-9. PubMed ID: 10537350
[TBL] [Abstract][Full Text] [Related]
9. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
[TBL] [Abstract][Full Text] [Related]
10. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of two fluorouracil administration regimens for colorectal cancer.
Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
[TBL] [Abstract][Full Text] [Related]
12. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas.
Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T
Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil-related gene expression in hepatic artery infusion-treated patients with hepatic metastases from colorectal carcinomas.
Sameshima S; Tomozawa S; Horikoshi H; Motegi K; Hirayama I; Koketsu S; Okada T; Kojima M; Kon Y; Sawada T
Anticancer Res; 2008; 28(1B):389-93. PubMed ID: 18383874
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
16. [Thymidylate synthase and dihydropyrimidine dehydrogenase gene expressions in colorectal cancer using the Danenberg tumor profile method].
Nagano H; Ichikawa W; Simizu M; Shirota Y; Nihei Z
Gan To Kagaku Ryoho; 2004 Jun; 31(6):889-92. PubMed ID: 15222106
[TBL] [Abstract][Full Text] [Related]
17. High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.
Kuramochi H; Hayashi K; Uchida K; Nakajima G; Hatori T; Danenberg KD; Danenberg PV; Yamamoto M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):85-9. PubMed ID: 18309485
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
[TBL] [Abstract][Full Text] [Related]
19. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T
Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
